Neil Dalvie is a graduate student in Chemical Engineering at MIT. He received his B.S. (2016) in Chemical Engineering from Northwestern University, where he worked on design principles for modular metabolite biosensors in bacteria.
At MIT, Neil applies tools from synthetic biology to enable low-cost manufacturing of therapeutic proteins in yeast. He established a platform for rapid, rational engineering of subunit vaccine antigens. This work culminated in a COVID-19 vaccine candidate for low-income countries that is in clinical development. In parallel, Neil developed genome...Read more